Carl Moeller, MD
Otolaryngology · Wethersfield, CTNPI 1124281464
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,439 of the $3,346 with a category attached, or 72.9%. Inspire Medical Systems, Inc. accounts for 82.0% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,792 and has fallen 88.7% since, to $203 in 2025.
Across 40 payments — averaging $83.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Stryker$138
- Davol Inc.$121
- Sanofi$96
- Regeneron Healthcare Solutions, Inc.$81
- GSK$64
- plus $101 from 3 others
What the payments were for
- Travel & lodging$90727%
- Food & beverage$2,43973%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 19 | $2,745 |
| Stryker | 4 | $138 |
| Davol Inc. | 1 | $121 |
| Sanofi | 5 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $81 |
| GSK | 3 | $64 |
| Acclarent, Inc | 2 | $61 |
| Precigen, Inc. | 1 | $22 |
| Johnson & Johnson | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,346 in reported general payments places this provider in the 70th percentile of 119 otolaryngology providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $48,651 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 54 | $4,333 |
| Ipratropium Bromide | 66 | $1,398 |
| Fluticasone Propionate | 54 | $1,230 |
| Mometasone Furoate | 11 | $868 |
| Fluocinolone Acetonide Oil | 23 | $597 |
| Azelastine Hcl | 22 | $373 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $204 |
| Omeprazole | 15 | $105 |
| Montelukast Sodium | 12 | $95 |
| Prednisone | 26 | $40 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Wethersfield
- Timothy ObrienWethersfield$4K
- Sara PaiNew Haven$160K
- Richard ManesNew Haven$67K
- Howard StupakWestport$48K
- Belachew TessemaFarmington$45K
- Seth BrownFarmington$39K
- Howard BoeyNew Haven$19K
- Mahesh BhayaWaterbury$11K
- Neil SchiffWaterbury$10K
- Benjamin WycherlyFarmington$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.